These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 10879223)

  • 1. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
    Hasnan J; Jayaram G
    Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of silver binding nucleolar organiser regions (AgNORs) of breast lesions in histological sections and fine needle aspiration smears.
    Basu A; Sanyal S; Bhattacharyya A; Bhattacharyya S; Dasgupta S
    J Indian Med Assoc; 1997 Aug; 95(8):443-7. PubMed ID: 9492450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of AgNORS in fine needle aspiration cytology of breast lesions.
    Rajeevan K; Aravindan KP; Kumari BC
    Indian J Pathol Microbiol; 1995 Jan; 38(1):17-24. PubMed ID: 8919465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolar organizer regions in human breast cancer.
    Roller E; Fritz P; Wicherek C; Klumpp B; Lauinger J; Mischlinski A; Wanner B; Schumacher K
    Zentralbl Pathol; 1993 Aug; 139(3):195-9. PubMed ID: 8218120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic relevance of silver stained nucleolar organizer region (AgNORs) in benign and malignant breast lesions.
    Agarwal PK; Mehrotra A; Chandra T
    Indian J Exp Biol; 1995 Oct; 33(10):715-20. PubMed ID: 8575800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast.
    Dube MK; Govil A
    Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cytological morphologic criteria and AgNOR expression in male breast lesions.
    Karakitsos P; Botsoli-Stergiou EM; Ioakim-Liossi A; Georgoulakis J; Markopoulos C; Gogas J; Kyrkou K
    Cytopathology; 1998 Apr; 9(2):107-13. PubMed ID: 9577737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolar organizer regions in breast cytology material.
    Rath-Wolfson L; Hamel I; Halpern M; Klein B; Gal R
    Acta Cytol; 1995; 39(5):852-7. PubMed ID: 7571959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of the "gray zone" in breast cytology. A review of 186 cases of atypical and suspicious cytology.
    al-Kaisi N
    Acta Cytol; 1994; 38(6):898-908. PubMed ID: 7992576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical significance of AgNOR counts in FNAC smears and corresponding histopathological sections.
    Mehrotra A; Chandra T
    Indian J Exp Biol; 1998 Feb; 36(2):162-6. PubMed ID: 9754045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of AgNOR method in thyroid cytopathology: correlation with morphometric measurements.
    Solymosi T; Tóth V; Sápi Z; Bodó M; Gál I; Csanádi L
    Diagn Cytopathol; 1996 Mar; 14(2):140-4. PubMed ID: 8964170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fine needle aspiration cytology and excisional biopsy in palpable breast cancers.
    Müslümanoğlu M; Dolay K; Ozmen V; Iğci A; Bozfakioğlu Y
    Radiol Med; 1995 Mar; 89(3):225-8. PubMed ID: 7754112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of fixation and preparation on the AgNOR distribution in routinely processed breast cancer specimens.
    Biesterfeld S; Ruoss E; Hufnagl P; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):41-8. PubMed ID: 7515672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silver-binding nucleoli and nucleolar organizer regions in fine needle aspiration cytology of the breast.
    Giri DD; Dundas SA; Sanderson PR; Howat AJ
    Acta Cytol; 1989; 33(2):173-5. PubMed ID: 2929216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized in situ AgNOR analysis in breast pathology: diagnostic and cell kinetic implications.
    Bànkfalvi A; Ofner D; Schmid KW; Schmitz KJ; Breukelmann D; Krech R; Böcker W
    Pathol Res Pract; 1999; 195(4):219-29. PubMed ID: 10337659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AgNOR, Ki-67 and PCNA expression in fibroepithelial tumours of the breast in correlation with morphological features.
    Barwijuk-Machała M; Musiatowicz B; Cylwik J; Reszeć J; Augustynowicz A
    Folia Morphol (Warsz); 2004 Feb; 63(1):133-5. PubMed ID: 15039920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of liquid-based cytology in the investigation of breast lesions using fine-needle aspiration: a cytohistopathological evaluation.
    Kontzoglou K; Moulakakis KG; Konofaos P; Kyriazi M; Kyroudes A; Karakitsos P
    J Surg Oncol; 2005 Feb; 89(2):75-8. PubMed ID: 15660372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [AgNOR in the pathologic differential diagnosis of tumors].
    Chen BF
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):463-6. PubMed ID: 1315672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolar organizer regions as discriminators for the diagnosis of well-differentiated adenocarcinoma of the prostate.
    Schned AR
    Arch Pathol Lab Med; 1993 Oct; 117(10):1000-4. PubMed ID: 8215819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.